FI902335A0 - Menetelmä terapeuttisesti käyttökelpoisten pyridopyridatsinonijohdannaisten valmistamiseksi - Google Patents

Menetelmä terapeuttisesti käyttökelpoisten pyridopyridatsinonijohdannaisten valmistamiseksi

Info

Publication number
FI902335A0
FI902335A0 FI902335A FI902335A FI902335A0 FI 902335 A0 FI902335 A0 FI 902335A0 FI 902335 A FI902335 A FI 902335A FI 902335 A FI902335 A FI 902335A FI 902335 A0 FI902335 A0 FI 902335A0
Authority
FI
Finland
Prior art keywords
compounds
pyrido
pyridazine
oxo
substituted
Prior art date
Application number
FI902335A
Other languages
English (en)
Swedish (sv)
Other versions
FI93013B (fi
FI93013C (fi
Inventor
Banavara Lakshmana Mylari
William James Zembrowski
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of FI902335A0 publication Critical patent/FI902335A0/fi
Publication of FI93013B publication Critical patent/FI93013B/fi
Application granted granted Critical
Publication of FI93013C publication Critical patent/FI93013C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • Biomedical Technology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Saccharide Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
FI902335A 1989-05-11 1990-05-10 Menetelmä terapeuttisesti käyttökelpoisten pyridopyridatsinonijohdannaisten valmistamiseksi FI93013C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US35041789 1989-05-11
US07/350,417 US4996204A (en) 1989-05-11 1989-05-11 Pyrido[2,3-d]pyridazinones as aldose reductase inhibitors

Publications (3)

Publication Number Publication Date
FI902335A0 true FI902335A0 (fi) 1990-05-10
FI93013B FI93013B (fi) 1994-10-31
FI93013C FI93013C (fi) 1995-02-10

Family

ID=23376622

Family Applications (1)

Application Number Title Priority Date Filing Date
FI902335A FI93013C (fi) 1989-05-11 1990-05-10 Menetelmä terapeuttisesti käyttökelpoisten pyridopyridatsinonijohdannaisten valmistamiseksi

Country Status (18)

Country Link
US (1) US4996204A (fi)
EP (1) EP0401981B1 (fi)
JP (1) JPH0631235B2 (fi)
KR (1) KR920003559B1 (fi)
AT (1) ATE121743T1 (fi)
AU (1) AU611610B2 (fi)
CA (1) CA2016326C (fi)
DE (1) DE69018876T2 (fi)
DK (1) DK0401981T3 (fi)
ES (1) ES2071016T3 (fi)
FI (1) FI93013C (fi)
HU (1) HU206714B (fi)
IE (1) IE66029B1 (fi)
IL (1) IL94302A (fi)
NO (1) NO173938C (fi)
NZ (1) NZ233599A (fi)
PT (1) PT93984B (fi)
ZA (1) ZA903564B (fi)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4954629A (en) * 1989-05-11 1990-09-04 Pfizer Inc. Process and intermediates for the preparation of oxophthalazinyl acetic acids and analogs thereof
US5716954A (en) * 1991-10-09 1998-02-10 Syntex U.S.A. Inc. Benzopyridazinone and pyridopyridazinone compounds
JP2789134B2 (ja) * 1992-09-28 1998-08-20 ファイザー・インク． 糖尿病の合併症を制御する置換ピリミジン類
GB9314412D0 (en) * 1993-07-13 1993-08-25 Rhone Poulenc Agriculture New compositions of matter
CN1205207C (zh) * 1998-03-31 2005-06-08 药品发现学会公司 取代的吲哚链烷酸
TNSN99224A1 (fr) 1998-12-01 2005-11-10 Inst For Pharm Discovery Inc Methodes de reduction des niveaux de glucose et triglyceride en serum et pour suppression de l'antigenese utilisant les acides la indolealkanoique
MXPA03004871A (es) * 2000-11-30 2003-08-19 Pfizer Prod Inc Combinacion de agonistas de gaba e inhibidores de aldosa-reductasa.
DE60204611T2 (de) 2001-02-28 2006-05-11 Pfizer Products Inc., Groton Sulfonyl-pyridazinon-derivate zur Verwendung als Aldose-reduktase-inhibitoren
IL156462A0 (en) * 2001-03-30 2004-01-04 Pfizer Prod Inc Pyridazinone aldose reductase inhibitors
JP2004528344A (ja) * 2001-04-30 2004-09-16 ファイザー・プロダクツ・インク アルドースレダクターゼ阻害薬とシクロオキシゲナーゼ−２阻害薬の併用
AU761191B2 (en) 2001-05-24 2003-05-29 Pfizer Products Inc. Therapies for tissue damage resulting from ischemia
US7572910B2 (en) * 2003-02-20 2009-08-11 Pfizer, Inc. Pyridazinone aldose reductase inhibitors
US8916563B2 (en) * 2010-07-16 2014-12-23 The Trustees Of Columbia University In The City Of New York Aldose reductase inhibitors and uses thereof
JP5934206B2 (ja) * 2010-07-16 2016-06-15 ザ・トラスティーズ・オブ・コロンビア・ユニバーシティ・イン・ザ・シティ・オブ・ニューヨーク アルドース還元酵素阻害剤および同使用方法
BR112018076244A2 (pt) 2016-06-21 2019-03-26 The Trustees Of Columbia University In The City Of New York inibidores da aldose redutase e métodos de uso destes
PL3658142T3 (pl) 2017-07-28 2024-08-26 Applied Therapeutics, Inc. Związki i sposoby leczenia galaktozemii
SG11202111822QA (en) 2019-05-07 2021-11-29 Univ Miami Treatment and detection of inherited neuropathies and associated disorders

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3821383A (en) * 1972-07-10 1974-06-28 Ayerst Mckenna & Harrison Compositions for and a method of treating diabetic complications
DE2708187A1 (de) * 1977-02-25 1978-08-31 Thomae Gmbh Dr K Neue pyrido-pyridazin-one
IE47592B1 (en) * 1977-12-29 1984-05-02 Ici Ltd Enzyme inhibitory phthalazin-4-ylacetic acid derivatives, pharmaceutical compositions thereof,and process for their manufacture
US4209527A (en) * 1979-05-16 1980-06-24 Pfizer Inc. Benzimidazolone derivatives
CA1160518A (en) * 1979-07-06 1984-01-17 E. I. Du Pont De Nemours And Company Coated cookware with fep topcoat
ES2032749T3 (es) * 1985-11-07 1993-03-01 Pfizer Inc. Acidos oxoftalazinil-aceticos heterociclicos.
US4954629A (en) * 1989-05-11 1990-09-04 Pfizer Inc. Process and intermediates for the preparation of oxophthalazinyl acetic acids and analogs thereof

Also Published As

Publication number Publication date
HU902996D0 (en) 1990-09-28
NO902070L (no) 1990-11-12
IL94302A (en) 1994-01-25
AU5490590A (en) 1990-11-15
PT93984B (pt) 1996-11-29
IE901701L (en) 1990-11-11
NO173938C (no) 1994-02-23
NO902070D0 (no) 1990-05-10
DK0401981T3 (da) 1995-09-04
KR920003559B1 (ko) 1992-05-04
CA2016326A1 (en) 1990-11-11
AU611610B2 (en) 1991-06-13
EP0401981B1 (en) 1995-04-26
CA2016326C (en) 1995-05-30
NZ233599A (en) 1991-07-26
DE69018876D1 (de) 1995-06-01
ATE121743T1 (de) 1995-05-15
FI93013B (fi) 1994-10-31
DE69018876T2 (de) 1995-08-24
HUT54683A (en) 1991-03-28
JPH0631235B2 (ja) 1994-04-27
US4996204A (en) 1991-02-26
KR900018092A (ko) 1990-12-20
NO173938B (no) 1993-11-15
EP0401981A1 (en) 1990-12-12
JPH035481A (ja) 1991-01-11
FI93013C (fi) 1995-02-10
IL94302A0 (en) 1991-03-10
HU206714B (en) 1992-12-28
ZA903564B (en) 1992-08-26
ES2071016T3 (es) 1995-06-16
PT93984A (pt) 1991-01-08
IE66029B1 (en) 1995-11-29

Similar Documents

Publication Publication Date Title
FI902335A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten pyridopyridatsinonijohdannaisten valmistamiseksi
PT85294A (en) Indolinone derivatives
DE3071230D1 (en) Substituted 6-phenethyl-and phenylethenyl-3,4,5,6-tetrahydro-4-hydroxytetraydropyran-2-ones in the4-r trans stereoisomeric forms and the corresponding dihydroxy acids, process for preparing and pharmaceutical composition comprising them
IE801005L (en) Benzimidazolones.
HUT62855A (en) Process for producing glycerol derivatives and pharmaceutical compositions comprising same
EG18597A (en) Process for the production of phthalazineacetic acid ester derivatives and a novel intermediate
JPS6429363A (en) Heterocyclic derivative

Legal Events

Date Code Title Description
FG Patent granted

Owner name: PFIZER INC.

BB Publication of examined application
MM Patent lapsed

Owner name: PFIZER INC.